Evidence of compensatory neural hyperactivity in a subgroup of breast cancer survivors treated with chemotherapy and its association with brain aging

IntroductionChemotherapy-related cognitive impairment (CRCI) remains poorly understood in terms of the mechanisms of cognitive decline. Neural hyperactivity has been reported on average in cancer survivors, but it is unclear which patients demonstrate this neurophenotype, limiting precision medicine...

Full description

Saved in:
Bibliographic Details
Main Authors: Michele M. Mulholland, Alexa Stuifbergen, Alexa De La Torre Schutz, Oscar Y. Franco Rocha, Douglas W. Blayney, Shelli R. Kesler
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2024.1421703/full
Tags: Add Tag
No Tags, Be the first to tag this record!